Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)
Guideline Development Group., Wim Van Biesen(Ghent University Hospital), James Heaf(Zealand University Hospital), Evi Nagler(Ghent University Hospital), Johan De Sutter(Ghent University Hospital), Luigi Gnudi(Harvard University), Ionuţ Nistor(Grigore T. Popa University of Medicine and Pharmacy), Luís Coentrão, Andrzej Więcek(Medical University of Silesia), Olof Heimbürger(Karolinska University Hospital), Steven Van Laecke(Ghent University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Davide Bolignano(Istituto di Fisiologia Clinica), Liesbeth Van Huffel, David Goldsmith(University College London), Christiane Drechsler(Universitätsklinikum Würzburg), Laurent Weekers, María José Soler(Mayo Clinic), Cécile Couchoud(Agence de la Biomédecine), Henk J.G. Bilo(University Medical Center Groningen), Maria Haller(Statistics Austria), Charles Tomson(Freeman Hospital), Hakan Nacak, Adrian Covic, Sabine N van der Veer(Ghent University Hospital)
Cited by 154
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.3k
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927